InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Walker Luke Nathaniel. Officer active across 2 companies, notably Harpoon Therapeutics, Inc.. Aggregated, 6 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €24k. Activity tracked since 26 November 2023. The latest transaction was disclosed on 17 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Walker Luke Nathaniel is a declarant linked to Harpoon Therapeutics, Inc. as Chief Medical Officer and to Zentalis Pharmaceuticals, Inc. as Director. He has 5 filings in total, and across the 5 sampled recent filings, buys amount to EUR 24012, sells amount to EUR 0, between 2023-11-28 and 2025-02-04.